Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease
about
Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expressionLow-density lipoprotein receptor-related protein 1 prevents early atherosclerosis by limiting lesional apoptosis and inflammatory Ly-6Chigh monocytosis: evidence that the effects are not apolipoprotein E dependentInhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque developmentLiver X receptor and peroxisome proliferator-activated receptor as integrators of lipid homeostasis and immunityCardiovascular disease in lupus: insights and updatesChemerin peptides promote phagocytosis in a ChemR23- and Syk-dependent mannerThe effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosusThe peroxisome proliferator-activated receptor gamma agonist rosiglitazone ameliorates murine lupus by induction of adiponectinACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.Cholesterol-induced membrane microvesicles as novel carriers of damage-associated molecular patterns: mechanisms of formation, action, and detoxification.Increased sensitivity of Apolipoprotein E knockout mice to swainsonine dependent immunomodulation.Macrophage death and defective inflammation resolution in atherosclerosis.TLR4 ligands induce IFN-alpha production by mouse conventional dendritic cells and human monocytes after IFN-beta primingTreatment with apolipoprotein A-1 mimetic peptide reduces lupus-like manifestations in a murine lupus model of accelerated atherosclerosis.Tyro3 receptor tyrosine kinases in the heterogeneity of apoptotic cell uptake.Adiponectin modulates inflammatory reactions via calreticulin receptor-dependent clearance of early apoptotic bodies.The Role of Efferocytosis in Atherosclerosis.Insulin resistance and atherosclerosis.IRF5 deficiency ameliorates lupus but promotes atherosclerosis and metabolic dysfunction in a mouse model of lupus-associated atherosclerosisHematopoietic Fas deficiency does not affect experimental atherosclerotic lesion formation despite inducing a proatherogenic state.Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells.The immunomodulatory parasitic worm product ES-62 reduces lupus-associated accelerated atherosclerosis in a mouse modelAtherosclerosis in systemic lupus erythematosus.Hypercholesterolemia and ApoE deficiency result in severe infection with Lyme disease and relapsing-fever Borrelia.Apoptotic neutrophils and T cells sequester chemokines during immune response resolution through modulation of CCR5 expression.Plasmacytoid dendritic cells in atherosclerosis.Type I interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosisApoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatoryA novel mouse model that develops spontaneous arthritis and is predisposed towards atherosclerosis.Distinct roles for complement in glomerulonephritis and atherosclerosis revealed in mice with a combination of lupus and hyperlipidemia.17-β Estradiol reduces atherosclerosis without exacerbating lupus in ovariectomized systemic lupus erythematosus-susceptible LDLr(-/-) mice.Accelerated atherosclerosis in ApoE deficient lupus mouse models.The link between antibodies to OxLDL and natural protection against pneumococci depends on D(H) gene conservation.Trypanosoma cruzi infection is enhanced by vector saliva through immunosuppressant mechanisms mediated by lysophosphatidylcholineAutoimmunity in atherosclerosis: a protective response losing control?Accelerated atherosclerosis is independent of feeding high fat diet in systemic lupus erythematosus-susceptible LDLr(-/-) mice.The inextricable link between atherosclerosis and prototypical inflammatory diseases rheumatoid arthritis and systemic lupus erythematosus.Immune and inflammatory mechanisms of atherosclerosis (*)Extravascular inflammation does not increase atherosclerosis in apoE-deficient mice.G2A and LPC: regulatory functions in immunity.
P2860
Q24314933-9197937A-16D7-40B4-82B5-224DA7B226F1Q24628806-AF4097D6-C783-4AA2-9191-3B1143BD8722Q24634492-0D349A82-D09F-43F0-B9AA-21E23A1BCDD8Q27013011-874E5180-08E0-403E-B86F-3ECA4D3A5C39Q27016554-FE87F6D8-7ED4-4B90-B4BE-599D583DDC91Q28278631-30284B3B-0F6F-4F0D-BFE2-4B03FE220A8CQ28486062-A372F947-312E-4744-BDDA-5B7F9F7A04E9Q28585701-B79A5FBD-E53B-424E-8A4B-C786011428F0Q30538414-A0748ACF-6E43-4FF6-A9D3-5B1788723150Q30664287-E76DCB3E-78D5-4278-B131-1982FC16922FQ33624935-D600634D-7CCA-4CD8-8554-EB1AF9C6CCB9Q33789327-232D5C8D-2951-4A58-A66F-A8BD401978CEQ33807599-DEAE9F9B-50DA-4F10-9106-8AC45BCF4C9EQ34027495-3D87F36C-A001-4030-9BE6-B72BF732AB0EQ34314664-306475D2-44D2-4A7C-B62D-4B140A631199Q34606650-66AE890D-84A9-4A64-8187-908EAB40C6ACQ34680660-8F827D94-D84F-44AD-A6D1-F085BD361BD2Q34698887-3D75DC1D-32EC-4B9D-9127-E9EC4522A456Q35070231-D5BDFD83-1F1F-41AB-BFFF-2A93F5B37CA2Q35070659-450336BA-9DC3-4B80-A23D-B3A7A265E623Q35152132-F760DC2E-2AB8-40E0-B71D-FF99E62C4FBCQ35164643-0B0C86CD-913C-49F8-ABFF-C412B4E7083DQ35525108-43AD4EB4-1E12-4723-B96F-455FA5BCEF21Q35567134-4789F871-2F4D-456A-AE3E-CE05238F1C5FQ35633812-B99BD67D-BFCB-4395-A57A-AEB7FCE70E21Q36064574-237F15B4-1717-464F-900A-51578DBF10FFQ36139902-4548D11F-9514-4246-94EE-F94A90A819FAQ36399652-780B64D5-C8D3-491E-B760-E1CE05515071Q36550836-4B65CC5B-5D94-4361-99A6-E23427343101Q36713445-5AA2A775-3664-42A3-8AFA-33FFCB4202D2Q36746168-339D37D0-FA89-4450-926B-FDC00BAC5ED8Q36766008-9041A568-71BC-4931-A54A-72D1D0CC0E56Q36822711-04F7AE55-D431-46C5-A1F7-F7DD37C767E6Q36974519-5BA23BAD-F9E3-4812-88C9-D83121E31437Q37138017-543C485C-50A8-427D-A59D-7E4D6485EF1DQ37143021-1D55F252-8BA4-4DAC-9378-EC3D659D08A9Q37206876-E188D5DA-8322-4EA8-AC99-5D933E6F47CDQ37325024-96D1D56B-4D36-4135-974E-53CE6522E22CQ37336947-5E459DB5-2B4D-4585-A63A-3E8FD8DF89A9Q37339837-932437C7-064A-4438-A19D-290F3646C21A
P2860
Impaired clearance of apoptotic cells promotes synergy between atherogenesis and autoimmune disease
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Impaired clearance of apoptoti ...... genesis and autoimmune disease
@ast
Impaired clearance of apoptoti ...... genesis and autoimmune disease
@en
type
label
Impaired clearance of apoptoti ...... genesis and autoimmune disease
@ast
Impaired clearance of apoptoti ...... genesis and autoimmune disease
@en
prefLabel
Impaired clearance of apoptoti ...... genesis and autoimmune disease
@ast
Impaired clearance of apoptoti ...... genesis and autoimmune disease
@en
P2093
P2860
P356
P1476
Impaired clearance of apoptoti ...... genesis and autoimmune disease
@en
P2093
Bénédicte Hugel
Ian Rifkin
Jean-Marie Freyssinet
John J Castellot
Kaori Sato
Kenneth Walsh
Ramon Bonegio
Tamar Aprahamian
P2860
P304
P356
10.1084/JEM.20031557
P407
P577
2004-04-01T00:00:00Z